Loading clinical trials...
Loading clinical trials...
Evaluation of the Association of Dialysis Dose Obtained by Kt and Mortality in Hemodialysis Patients
The aim of this study is to assess whether patients receiving current recommendations of an adequate dialysis dose by Kt adjusted for body surface area improved survival at 24 months compared to those who do not get it, as well as assess whether patients receiving a dose greater obtain more benefit.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
NephroCare Spain
Madrid, Madrid, Spain
Start Date
October 1, 2013
Primary Completion Date
December 1, 2013
Completion Date
December 1, 2015
Last Updated
July 13, 2016
6,129
ACTUAL participants
Lead Sponsor
NephroCare Spain
NCT07146854
NCT04163614
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04580420